Tag Archives: Beyaz
-
-
Conflict of Interest Concerns Lead to Calls for New Yaz Safety Meeting
-
Yaz FDA Panelists Served as Consultants, Speakers, Researchers for Bayer
-
Yaz Settlement Negotiations Ordered as First Trial in MDL Delayed
-
Yasmin, Yaz Recall Not Recommended, Stronger Warnings Are: FDA Panel
-
Yasmin, Yaz Warnings Should Be Added: FDA Staff
-
Yasmin, Yaz Blood Clot Risk 1.5 to 3 Times Higher Than Other Pills: Canada
-
Generic Yaz Birth Control by Watson Approved
-
Judge Blocks Confidential Yaz Litigation Files from Going to FDA
-
FDA Study Suggests Yasmin, Yaz Blood Clot Risk is 75% Higher